Ca2+ microdomains organized by junctophilins

Cell Calcium

Volumn 58, Issue 4, 2015, Pages 349-356

  Takeshima, Hiroshi ^a   Hoshijima, Masahiko ^b   Song, Long Sheng ^c  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Calcium channel; Excitation contraction coupling; Muscle

Indexed keywords

JUNCTOPHILIN 1 PROTEIN; JUNCTOPHILIN 2 PROTEIN; JUNCTOPHILIN 3 PROTEIN; JUNCTOPHILIN 4 PROTEIN; MUSCLE PROTEIN; UNCLASSIFIED DRUG; CALCIUM; JUNCTOPHILIN; MEMBRANE PROTEIN;

CALCIUM SIGNALING; CELL MEMBRANE; COMPLEX FORMATION; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM; EXCITABLE MEMBRANE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUNTINGTON CHOREA; HYPERTROPHIC CARDIOMYOPATHY; JUNCTIONAL MEMBRANE COMPLEXES; MOLECULAR PHYLOGENY; MUSCLE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; METABOLISM; NERVE CELL; PHYSIOLOGY; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; NEURONS; SARCOPLASMIC RETICULUM;

EID: 84940900383     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2015.01.007     Document Type: Review

References (86)

1. Porter K.R., Palade G.E. Studies on the endoplasmic reticulum. III. Its form and distribution in striated muscle cells. J. Biophys. Biochem. Cytol. 1957, 3:269-300.
2. Friedman J.R., Voeltz G.K. The ER in 3D: a multifunctional dynamic membrane network. Trends Cell Biol. 2011, 21:709-717.
3. Rosenbluth J. Subsurface cisterns and their relationship to the neuronal plasma membrane. J. Cell Biol. 1962, 13:405-421.
4. Franzini-Armstrong C., Protasi F. Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol. Rev. 1997, 77:699-729.
5. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
6. Shen W.W., Frieden M., Demaurex N. Remodelling of the endoplasmic reticulum during store-operated calcium entry. Biol. Cell 2011, 103:365-380.
7. 2+ delivery system in muscle cells. Appl. Physiol. Nutr. Metab. 2009, 34:323-327.
8. 2+ signaling in the heart. J. Cell Sci. 2009, 122:1005-1013.
9. Soeller C., Cannell M.B. Examination of the transverse tubular system in living cardiac rat myocytes by 2-photon microscopy and digital image-processing techniques. Circ. Res. 1999, 84:266-275.
10. Wagner E., Lauterbach M.A., Kohl T., Westphal V., Williams G.S., Steinbrecher J.H., Streich J.H., Korff B., Tuan H.T., Hagen B., Luther S., Hasenfuss G., Parlitz U., Jafri M.S., Hell S.W., Lederer W.J., Lehnart S.E. Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction. Circ. Res. 2012, 111:402-414.
11. Pinali C., Bennett H., Davenport J.B., Trafford A.W., Kitmitto A. Three-dimensional reconstruction of cardiac sarcoplasmic reticulum reveals a continuous network linking transverse-tubules: this organization is perturbed in heart failure. Circ. Res. 2013, 113:1219-1230.
12. Huxley A.F., Taylor R.E. Local activation of striated muscle fibres. J. Physiol. 1958, 144:426-441.
13. Ziman A.P., Gomez-Viquez N.L., Bloch R.J., Lederer W.J. Excitation-contraction coupling changes during postnatal cardiac development. J. Mol. Cell. Cardiol. 2010, 48:379-386.
14. Di Maio A., Karko K., Snopko R.M., Mejia-Alvarez R., Franzini-Armstrong C. T-tubule formation in cardiacmyocytes: two possible mechanisms. J. Muscle Res. Cell Motil. 2007, 28:231-241.
15. Das T., Hoshijima M. Adding a new dimension to cardiac nano-architecture using electron microscopy: coupling membrane excitation to calcium signaling. J. Mol. Cell. Cardiol. 2013, 58:5-12.
16. Stern M.D. Theory of excitation-contraction coupling in cardiac muscle. Biophys. J. 1992, 63:497-517.
17. Stern M.D., Pizarro G., Rios E. Local control model of excitation-contraction coupling in skeletal muscle. J. Gen. Physiol. 1997, 110:415-440.
18. Fabiato A., Fabiato F. Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat, and frog hearts and from fetal and new-born rat ventricles. Ann. N. Y. Acad. Sci. 1978, 307:491-522.
19. Felder E., Protasi F., Hirsch R., Franzini-Armstrong C., Allen P.D. Morphology and molecular composition of sarcoplasmic reticulum surface junctions in the absence of DHPR and RyR in mouse skeletal muscle. Biophys. J. 2002, 82:3144-3149.
20. Paolini C., Quarta M., Nori A., Boncompagni S., Canato M., Volpe P., Allen P.D., Reggiani C., Protasi F. Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J. Physiol. 2007, 583:767-784.
21. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J. Clin. Investig. 2006, 116:2510-2520.
22. 2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7636-7641.
23. Shen X., Franzini-Armstrong C., Lopez J.R., Jones L.R., Kobayashi Y.M., Wang Y., Kerrick W.G., Caswell A.H., Potter J.D., Miller T., Allen P.D., Perez C.F. Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle. J. Biol. Chem. 2007, 282:37864-37874.
24. Wong J., Baddeley D., Bushong E.A., Yu Z., Ellisman M.H., Hoshijima M., Soeller C. Nanoscale distribution of ryanodine receptors and caveolin-3 in mouse ventricular myocytes: dilation of T-tubules near junctions. Biophys. J. 2013, 104:L22-L24.
25. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., Hou H., Kneitz B., Edelmann W., Lisanti M.P. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J. Biol. Chem. 2001, 276:21425-21433.
26. Woodman S.E., Park D.S., Cohen A.W., Cheung M.W., Chandra M., Shirani J., Tang B., Jelicks L.A., Kitsis R.N., Christ G.J., Factor S.M., Tanowitz H.B., Lisanti M.P. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J. Biol. Chem. 2002, 277:38988-38997.
27. Prokic I., Cowling B.S., Laporte J. Amphiphysin 2 (BIN1) in physiology and diseases. J. Mol. Med. 2014, 92:453-463.
28. Hong T.T., Smyth J.W., Chu K.Y., Vogan J.M., Fong T.S., Jensen B.C., Fang K., Halushka M.K., Russell S.D., Colecraft H., Hoopes C.W., Ocorr K., Chi N.C., Shaw R.M. BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm 2012, 9:812-820.
29. Lee E., Marcucci M., Daniell L., Pypaert M., Weisz O.A., Ochoa G.C., Farsad K., Wenk M.R., De Camilli P. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science 2002, 297:1193-1196.
30. Hong T., Yang H., Zhang S.S., Cho H.C., Kalashnikova M., Sun B., Zhang H., Bhargava A., Grabe M., Olgin J., Gorelik J., Marban E., Jan L.Y., Shaw R.M. Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. Nat. Med. 2014, 20:624-632.
31. Takeshima H., Shimuta M., Komazaki S., Ohmi K., Nishi M., Iino M., Miyata A., Kangawa K. Mitsugumin29, a novel synaptophysin family member from the triad junction in skeletal muscle. Biochem. J. 1998, 331(Pt. 1):317-322.
32. M. Nishi, S. Komazaki, N. Kurebayashi, Y. Ogawa, T. Noda, M. Iino, H. Takeshima, Abnormal features in skeletal muscle from mice lacking mitsugumin29, J. Cell Biol. 147 (1999), 1473-1480.
33. Takeshima H., Komazaki S., Nishi M., Iino M., Kangawa K. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell 2000, 6:11-22.
34. Nishi M., Sakagami H., Komazaki S., Kondo H., Takeshima H. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003, 118:102-110.
35. S. Kakizawa, S. Moriguchi, A. Ikeda, M. Iino and H. Takeshima, Functional crosstalk between cell-surface and intracellular channels mediated by junctophilins essential for neuronal functions, Cerebellum7, 2008, 385-391.
36. Bennett H.J., Davenport J.B., Collins R.F., Trafford A.W., Pinali C., Kitmitto A. Human junctophilin-2 undergoes a structural rearrangement upon binding PtdIns(3,4,5)P3 and the S101R mutation identified in hypertrophic cardiomyopathy obviates this response. Biochem. J. 2013, 456:205-217.
37. Ma H., Lou Y., Lin W.H., Xue H.W. MORN motifs in plant PIPKs are involved in the regulation of subcellular localization and phospholipid binding. Cell Res. 2006, 16:466-478.
38. Minamisawa S., Oshikawa J., Takeshima H., Hoshijima M., Wang Y., Chien K.R., Ishikawa Y., Matsuoka R. Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. Biochem. Biophys. Res. Commun. 2004, 325:852-856.
39. 2+ channel dihydropyridine receptors (DHPRs) in skeletal muscle. J. Biol. Chem. 2011, 286:43717-43725.
40. Phimister A.J., Lango J., Lee E.H., Ernst-Russell M.A., Takeshima H., Ma J., Allen P.D., Pessah I.N. Conformation-dependent stability of junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J. Biol. Chem. 2007, 282:8667-8677.
41. Beavers D.L., Wang W., Ather S., Voigt N., Garbino A., Dixit S.S., Landstrom A.P., Li N., Wang Q., Olivotto I., Dobrev D., Ackerman M.J., Wehrens X.H. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J. Am. Coll. Cardiol. 2013, 62:2010-2019.
42. Chen B., Guo A., Zhang C., Chen R., Zhu Y., Hong J., Kutschke W., Zimmerman K., Weiss R.M., Zingman L., Anderson M.E., Wehrens X.H., Song L.S. Critical roles of junctophilin-2 in T-tubule and excitation-contraction coupling maturation during postnatal development. Cardiovasc. Res. 2013, 100:54-62.
43. Reynolds J.O., Chiang D.Y., Wang W., Beavers D.L., Dixit S.S., Skapura D.G., Landstrom A.P., Song L.S., Ackerman M.J., Wehrens X.H. Junctophilin-2 is necessary for T-tubule maturation during mouse heart development. Cardiovasc. Res. 2013, 100:44-53.
44. Ito K., Komazaki S., Sasamoto K., Yoshida M., Nishi M., Kitamura K., Takeshima H. Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. J. Cell Biol. 2001, 154:1059-1067.
45. Komazaki S., Ito K., Takeshima H., Nakamura H. Deficiency of triad formation in developing skeletal muscle cells lacking junctophilin type 1. FEBS Lett. 2002, 524:225-229.
46. Komazaki S., Nishi M., Takeshima H. Abnormal junctional membrane structures in cardiac myocytes expressing ectopic junctophilin type 1. FEBS Lett. 2003, 542:69-73.
47. 2+ release and after hyperpolarization in mutant hippocampal neurons lacking junctophilins. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10811-10816.
48. S. Kakizawa, Y. Kishimoto, K. Hashimoto, T. Miyazaki, K. Furutani, H. Shimizu, M. Fukaya, M. Nishi, H. Sakagami, A. Ikeda, H. Kondo, M. Kano, M. Watanabe, M. Iino and H. Takeshima, Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity, EMBO J.26, 2007, 1924-1933.
49. Moriguchi S., Nishi M., Sasaki Y., Takeshima H., Fukunaga K. Aberrant behavioral sensitization by methamphetamine in junctophilin-deficient mice. Mol. Neurobiol. 2014, 10.1007/s12035-014-8737-2.
50. Yamazaki D., Tabara Y., Kita S., Hanada H., Komazaki S., Naitou D., Mishima A., Nishi M., Yamamura H., Yamamoto S., Kakizawa S., Miyachi H., Yamamoto S., Miyata T., Kawano Y., Kamide K., Ogihara T., Hata A., Umemura S., Soma M., Takahashi N., Imaizumi Y., Miki T., Iwamoto T., Takeshima H. TRIC-A channels in vascular smooth muscle contribute to blood pressure maintenance. Cell Metab. 2011, 14:231-241.
51. Fahrner M., Derler I., Jardin I., Romanin C. The STIM1/Orai signaling machinery. Channels 2013, 7:330-343.
52. Hogan P.G., Lewis R.S., Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 2010, 28:491-533.
53. 2+ entry uncoupled with ryanodine receptor and junctional membrane complex in heart muscle cells. Cell Calcium 2002, 31:89-96.
54. 2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. Biophys. J. 2006, 90:4418-4427.
55. 2+ loading in quiescent junctophilin 1 knock-out myotubes. J. Biol. Chem. 2010, 285:39171-39179.
56. Pla-Martin D., Calpena E., Lupo V., Marquez C., Rivas E., Sivera R., Sevilla T., Palau F., Espinos C. Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease. Hum. Mol. Genet. 2014.
57. Zhang H.B., Li R.C., Xu M., Xu S.M., Lai Y.S., Wu H.D., Xie X.J., Gao W., Ye H., Zhang Y.Y., Meng X., Wang S.Q. Ultrastructural uncoupling between T-tubules and sarcoplasmic reticulum in human heart failure. Cardiovasc. Res. 2013, 98:269-276.
58. Landstrom A.P., Kellen C.A., Dixit S.S., van Oort R.J., Garbino A., Weisleder N., Ma J., Wehrens X.H., Ackerman M.J. Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ. Heart Fail 2011, 4:214-223.
59. 2+ channel and ryanodine receptor signaling in hypertrophy. PLoS Biol. 2007, 5:e21.
60. Wei S., Guo A., Chen B., Kutschke W., Xie Y.P., Zimmerman K., Weiss R.M., Anderson M.E., Cheng H., Song L.S. T-tubule remodeling during transition from hypertrophy to heart failure. Circ. Res. 2010, 107:520-531.
61. Xu M., Wu H.D., Li R.C., Zhang H.B., Wang M., Tao J., Feng X.H., Guo Y.B., Li S.F., Lai S.T., Zhou P., Li L.L., Yang H.Q., Luo G.Z., Bai Y., Xi J.J., Gao W., Han Q.D., Zhang Y.Y., Wang X.J., Meng X., Wang S.Q. Mir-24 regulates junctophilin-2 expression in cardiomyocytes. Circ. Res. 2012, 111:837-841.
62. Chen B., Li Y., Jiang S., Xie Y.P., Guo A., Kutschke W., Zimmerman K., Weiss R.M., Miller F.J., Anderson M.E., Song L.S. β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction. FASEB J. 2012, 26:2531-2537.
63. Xie Y.P., Chen B., Sanders P., Guo A., Li Y., Zimmerman K., Wang L.C., Weiss R.M., Grumbach I.M., Anderson M.E., Song L.S. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension. Hypertension 2012, 59:355-362.
64. Wu C.Y., Chen B., Jiang Y.P., Jia Z., Martin D.W., Liu S., Entcheva E., Song L.S., Lin R.Z. Calpain-dependent cleavage of junctophilin-2 and T-tubule remodeling in a mouse model of reversible heart failure. J. Am. Heart Assoc. 2014, 3:e000527.
65. 2+ handling dysfunction in heart failure. Circulation 2014, 129:1742-1750.
66. Wu H.D., Xu M., Li R.C., Guo L., Lai Y.S., Xu S.M., Li S.F., Lu Q.L., Li L.L., Zhang H.B., Zhang Y.Y., Zhang C.M., Wang S.Q. Ultrastructural remodelling of Ca(2+) signalling apparatus in failing heart cells. Cardiovasc. Res. 2012, 95:430-438.
67. Han J., Wu H., Wang Q., Wang S. Morphogenesis of T-tubules in heart cells: the role of junctophilin-2. Sci. China Life Sci. 2013, 56:647-652.
68. Guo A., Zhang C., Wei S., Chen B., Song L.S. Emerging mechanisms of T-tubule remodelling in heart failure. Cardiovasc. Res. 2013, 98:204-215.
69. van Oort R.J., Garbino A., Wang W., Dixit S.S., Landstrom A.P., Gaur N., De Almeida A.C., Skapura D.G., Rudy Y., Burns A.R., Ackerman M.J., Wehrens X.H. Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice. Circulation 2011, 123:979-988.
70. Wu C.Y., Jia Z., Wang W., Ballou L.M., Jiang Y.P., Chen B., Mathias R.T., Cohen I.S., Song L.S., Entcheva E., Lin R.Z. PI3Ks maintain the structural integrity of T-tubules in cardiac myocytes. PLoS One 2011, 6:e24404.
71. Guo A., Zhang X., Iyer V.R., Chen B., Zhang C., Kutschke W.J., Weiss R.M., Franzini-Armstrong C., Song L.S. Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:12240-12245.
72. Matsushita Y., Furukawa T., Kasanuki H., Nishibatake M., Kurihara Y., Ikeda A., Kamatani N., Takeshima H., Matsuoka R. Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy. J. Hum. Genet. 2007, 52:543-548.
73. Landstrom A.P., Weisleder N., Batalden K.B., Bos J.M., Tester D.J., Ommen S.R., Wehrens X.H., Claycomb W.C., Ko J.K., Hwang M., Pan Z., Ma J., Ackerman M.J. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J. Mol. Cell. Cardiol. 2007, 42:1026-1035.
74. 2+ signalling in skeletal muscle. Biochem. J. 2010, 427:125-134.
75. 2+ entry via Orai1. J. Biol. Chem. 2012, 287:14336-14348.
76. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18255-18260.
77. Li R.C., Tao J., Guo Y.B., Wu H.D., Liu R.F., Bai Y., Lv Z.Z., Luo G.Z., Li L.L., Wang M., Yang H.Q., Gao W., Han Q.D., Zhang Y.Y., Wang X.J., Xu M., Wang S.Q. In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circ. Res. 2013, 112:601-605.
78. Zatz M., Starling A. Calpains and disease. N. Engl. J. Med. 2005, 352:2413-2423.
79. Patterson C., Portbury A.L., Schisler J.C., Willis M.S. Tear me down: role of calpain in the development of cardiac ventricular hypertrophy. Circ. Res. 2011, 109:453-462.
80. 2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle. J. Physiol. 2013, 591:719-729.
81. Cooper G.t. Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1003-H1014.
82. Webster D.R. Microtubules in cardiac toxicity and disease. Cardiovasc. Toxicol. 2002, 2:75-89.
83. Holmes S.E., O'Hearn E., Rosenblatt A., Callahan C., Hwang H.S., Ingersoll-Ashworth R.G., Fleisher A., Stevanin G., Brice A., Potter N.T., Ross C.A., Margolis R.L. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 2001, 29:377-378.
84. Govert F., Schneider S.A. Huntington's disease and Huntington's disease-like syndromes: an overview. Curr. Opin. Neurol. 2013, 26:420-427.
85. Seixas A.I., Holmes S.E., Takeshima H., Pavlovich A., Sachs N., Pruitt J.L., Silveira I., Ross C.A., Margolis R.L., Rudnicki D.D. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Ann. Neurol. 2012, 71:245-257.
86. Garbino A., Wehrens X.H. Emerging role of junctophilin-2 as a regulator of calcium handling in the heart. Acta Pharmacol. Sin. 2010, 31:1019-1021.